Skip to main content
Equibles
OPCH logo

OPCH · Option Care Health, Inc. · Metrics

Track OPCH — free

Use OPCH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.75 +0.01 (+0.04%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.80B
Shares
157.03M

OPCH metrics

90 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.74
Market cap
$3.80B

Price action

20 metrics
Price change (1W)
+1.3%
Price change (30D)
-1.2%
Price change (3M)
+18.0%
Price change (6M)
-18.9%
Price change (YTD)
-24.0%
Price change (1Y)
-15.9%
Trailing year
Price change (5Y)
-13.1%
52-week high
$36.59
52-week low
$19.52
Change from 52-week high
-33.8%
Change from 52-week low
+24.0%
Annualized volatility
41.7%
Annualized volatility (3M)
33.6%
Beta
0.0
RSI (14D)
59.0
Price vs SMA 50
+6.2%
Price vs SMA 200
-11.0%
Avg volume (3M)
2.43M
Relative volume
0.5
Average dollar volume
$54.35M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
157.03M

Valuation

12 metrics
P / E (TTM)
18.9
Trailing earnings · reciprocal yield 5.3%
PEG ratio
5.3
EV / revenue
0.8×
reciprocal yield 118.5%
EV / EBITDA
12.0×
reciprocal yield 8.3%
EV / EBIT
14.4×
reciprocal yield 6.9%
P / sales
0.7×
reciprocal yield 149.1%
P / book
2.8
reciprocal yield 35.5%
FCF yield
5.6%
TTM · current market cap
Buyback yield
—
P / FCF
17.9
reciprocal yield 5.6%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
5.4%

Historical valuation

8 metrics
P / E historical average (3Y)
23.3×
reciprocal yield 4.3%
P / E historical average (5Y)
25.8×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
1.2×
reciprocal yield 82.5%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 72.7%
EV / EBIT historical average (3Y)
18.4×
reciprocal yield 5.4%
EV / EBIT historical average (5Y)
22.8×
reciprocal yield 4.4%
EV / EBITDA historical average (3Y)
15.3×
reciprocal yield 6.5%
EV / EBITDA historical average (5Y)
18.0×
reciprocal yield 5.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
19.2%
Operating margin
5.8%
Trailing 12 months
Net margin
3.6%
Gross profit (TTM)
$1.09B
Operating profit (TTM)
$331.26M
Net income (TTM)
$206.19M
Trailing 12 months
Diluted EPS (TTM)
$1.28
FCF margin
3.8%
Effective tax rate
26.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$14.88

Growth

11 metrics
Revenue growth YoY
+1.3%
Year over year
Net income growth YoY
-3.0%
Revenue (TTM)
$5.67B
Trailing 12 months
EPS growth YoY
+3.6%
Shares change YoY
-5.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.7%
Revenue CAGR (5Y)
+13.3%
EPS CAGR (3Y)
+15.2%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-2.2%
FCF CAGR (5Y)
+16.7%

Quality

14 metrics
Return on equity
15.3%
Return on assets
6.1%
Debt / equity
0.9
Current ratio
1.6
EBITDA (TTM)
$397.96M
Free cash flow (TTM)
$212.57M
Quick ratio
1.1
Interest coverage
6.1
Net debt / EBITDA
2.5
Return on invested capital
10.4%
Trailing 12 months
Net cash
−$982.50M
Latest balance sheet
Cash & equivalents
$177.32M
Total assets
$3.38B
Total debt
$1.16B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$253.55M
Capital expenditures (TTM)
$40.98M
R&D (TTM)
—
SG&A (TTM)
$688.89M
Stock compensation (TTM)
$41.35M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
375
13F filer change QoQ
-2
Institutional ownership
101.2%

Short interest

3 metrics
Short interest
7.7%
Latest settlement · 5.3 days to cover
Days to cover
5.3d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1014739 CUSIP 68404L201 13F (30d) 221 filings 220 filers Visit website Investor relations